Melissa Moore-Clingenpeel

Director of Biostatistics for Phamacovigilance
CorEvitas

Poster(s):

• (C-148) Beyond Comparison: Target Trial Emulation (TTE) Principles Strengthen Observational Single-Arm (SA) Effectiveness Studies
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (C-149) Longitudinal, Regulatory-Grade Registry Data Can Be Used to Emulate a Target Trial: An Application on Evaluating Treatments for Plaque Psoriasis
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (C-156) Nuances of Risk Window Selection for Evaluation of Acute Adverse Events
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (C-206) Real-World Prospective Data Assessing the Long-Term Safety of Abrocitinib Treatment in Adults with Moderate to Severe Atopic Dermatitis (AD): Over Two years of Experience from the CorEvitas AD Registry
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (C-150) Review of Post-Authorization Safety Studies Submitted to the HMA-EMA Catalogue of RWD Studies Evaluating Cancer as an Outcome
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET